ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Co-delivery of Phagocytosis Checkpoint Silencer and Stimulator of Interferon Genes Agonist for Synergetic Cancer Immunotherapy

Lu, Zi-Dong; Chen, Yi-Fang; Shen, Song; Xu, Cong-Fei*; Wang, Jun
ACS applied materials & interfaces2021-6-30DOI: 10.1021/acsami.1c08329
14被引7阅读
引用收藏
分享

摘要

Efficient capture and presentation of tumor antigens by antigen-presenting cells (APCs), especially dendritic cells (DCs), are crucial for activating the anti-tumor immunity. However, APCs are immunosuppressed in the tumor microenvironment, which hinders the tumor elimination. To reprogram APCs for inducing strong anti-tumor immunity, we report here a co-delivery immunotherapeutic strategy targeting the phagocytosis checkpoint (signal regulatory protein alpha, SIRP alpha) and stimulator of interferon genes (STING) of APCs to jointly enhance their ability of capturing and presenting tumor antigens. In brief, a small interfering RNA targeting SIRP alpha (siSIRP alpha) and a STING agonist (cGAMP) were co-delivered into APCs by the encapsulation into poly(ethylene glycol)-b-poly(lactide-co-glycolide)-based polymeric nanoparticles (NPsiSIRP alpha/cGAMP). siSIRP alpha-mediated SIRP alpha silence promoted APCs to actively capture tumor antigens by engulfing tumor cells. The cGAMP-stimulated STING signaling pathway further enhanced the functions of APCs, thereby increased the activation and expansion of CD8(+) T cells. Using ovalbumin (OVA)-expressing melanoma as a model, we demonstrated that NPsiSIRP alpha/cGAMP stimulated the activation of OVA-specific CD8(+) T cells and induced holistic anti-tumor immune responses by reversing the immunosuppressive phenotype of APCs. Collectively, this co-delivery strategy synergistically enhanced the functions of APCs and can be extended to the treatment of tumors with poor immunogenicity.

学科与关键词

关键词
cancer immunotherapySTINGphagocytosis checkpointSIRP alphapolymeric nanoparticle
相关
加载中…
  • Nanoparticle-enabled concurrent modulation of phagocytosis and repolarization of macrophages for enhanced cancer immunotherapy
    Zhang, Jing-Yang; Chen, Fang -Man; Liu, Rong; Luo, Jia-Qi; Huang, Yong-Cong; Shu, Na; Zheng, Sui-Juan; Shao, Dan; Leong, Kam W.*; Du, Jin-Zhi*Nano Today, 2022, 47: 101651.被引 2
  • A siRNA-Assisted Assembly Strategy to Simultaneously Suppress "Self" and Upregulate "Eat-Me" Signals for Nanoenabled Chemo-Immunotherapy
    Zhang, Yuxi; Zhang, Zhenghai; Li, Senlin; Zhao, Liang; Li, Dongdong; Cao, Ziyang; Xu, Xiaoding; Yang, Xianzhu*ACS Nano, 2021, 15(10): 16030-16042.被引 41
  • Programmable Delivery of Immune Adjuvant to Tumor-Infiltrating Dendritic Cells for Cancer Immunotherapy
    Liu, Jing; Li, Hong-Jun; Luo, Ying-Li; Chen, Yi-Fang; Fan, Ya-Nan; Du, Jin-Zhi; Wang, Jun*Nano Letters, 2020, 20(7): 4882-4889.被引 47
查看全部 →

发表信息

论文状态
公开发表
期刊
ACS applied materials & interfaces
发表日期
2021-06-30
卷期
第 13 卷, 第 25 期
页码
29424-29438
DOI
10.1021/acsami.1c08329
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
National Key R&D Program of China [2017YFA0205600]; National Natural Science Foundation of China [82072048, 81901875, 81801825, 32071380, 51633008]; Program for Guangdong Introducing Innovative and Entrepreneurial Teams [2017ZT07S054]; Guangdong Provincial Pearl River Talents Program [2017GC010713]; Guangdong Basic and Applied Basic Research Foundation [2018A030310366, 2019A1515010627]; Science and Technology Program of Guangzhou, China [201904010306]; Fundamental Research Funds for the Central Universities

作者

  • L

    Lu, Zi-Dong (第一作者)

  • C

    Chen, Yi-Fang

查看全部 5 位作者收起作者
  • S

    Shen, Song

  • X

    Xu, Cong-Fei (通讯)

  • W

    Wang, Jun

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417